Title of article :
Reduced graphene oxide decorated with gold nanoparticle as signal amplification element on ultra-sensitive electrochemiluminescence determination of caspase-3 activity and apoptosis using peptide based biosensor
Author/Authors :
Rashidi Mohammad-Reza Research Center for Pharmaceutical Nanotechnology (RCPN) - Tabriz University of Medical Sciences - Tabriz, Iran , Khalilzadeh Balal Research Center for Pharmaceutical Nanotechnology (RCPN) - Tabriz University of Medical Sciences - Tabriz, Iran , Afsharan Hadi Research Center for Pharmaceutical Nanotechnology (RCPN) - Tabriz University of Medical Sciences - Tabriz, Iran , Eskandani Morteza Research Center for Pharmaceutical Nanotechnology (RCPN) - Tabriz University of Medical Sciences - Tabriz, Iran , Shadjou Nasrin Department of Nanochemistry and Nanotechnology Center - Urmia University - Urmia, Iran , Nozad Charoudeh Hojjatollah Stem Cell Research Center - Tabriz University of Medical Sciences - Tabriz, Iran
Abstract :
Growing demands for ultrasensitive
biosensing have led to the development of numerous
signal amplification strategies. In this report, a novel
electrochemiluminescence (ECL) method was
developed for the detection and determination of
caspase-3 activity based on reduced graphene oxide
sheets decorated by gold nanoparticles as signal
amplification element and horseradish peroxidase
enzyme (HRP) as ECL intensity enhancing agent.
Methods: The ECL intensity of the luminol was
improved by using the streptavidin coated magnetic
beads and HRP in the presence of hydrogen peroxide. The cleavage behavior of caspase-3 was
characterized by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS)
techniques using biotinylated peptide (DEVD containing peptide) which was coated on reduced
graphene oxide decorated with gold nanoparticle. The surface modification of graphene oxide
was successfully confirmed by FTIR, UV-vis and x-ray spectroscopy.
Results: ECL based biosensor showed that the linear dynamic range (LDR) and the lower limit
of quantification (LLOQ) were 0.5-100 and 0.5 femtomolar (fM), respectively. Finally, the
performance of the engineered peptide based biosensor was validated in the A549 cell line as real
samples.
Conclusion: The prepared peptide based biosensor could be considered as an excellent candidate
for early detection of apoptosis, cell turnover, and cancer related diseases.
Keywords :
Apoptosis , Caspase-3 , DEVD-peptide , Electrochemiluminescence , Gold nanoparticle , Reduced graphene oxide
Journal title :
Bioimpacts